Robert G.

Robert G. has extensive experience in pharmaceutical development and clinical operations, currently serving as Specialist II in Global CMC Development, Business Operations, and Clinical Operations at Ultragenyx since June 2021. Prior to this role, Robert worked at Biogen from June 2019 to June 2021 as a Protein & Gene Therapy Drug Product Engineer, where responsibilities included various aspects of business operations within pharmaceutical development. Robert holds a Master's degree in Chemical Engineering from The Cooper Union for the Advancement of Science and Art, along with a Bachelor's degree in Chemical Engineering from the same institution, and completed the Technology Leadership Program at the University of California, Berkeley, Haas School of Business. Robert's foundational education includes graduation from Brooklyn Technical High School.